Y0002407

Brivaracetam CRS

European Pharmacopoeia (EP) Reference Standard

• 別名: Brivaracetam, (αS,4R)-α-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide, (2S)-2-[(4R)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide, (S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide, UCB 34714, UCB-34714, UCB34714
• 実験式（ヒル表記法）: C₁₁H₂₀N₂O₂
• CAS番号: 357336-20-0
• 分子量: 212.29
• MDL番号: MFCD25976668
• UNSPSCコード: 41116107
• UNSPSCコード: 12352200
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• メーカー／製品名: EDQM
• アプリケーション: pharmaceutical
• 保管温度: 2-8°C

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. Compendial materials should be used for the purpose described in the appropriate monograph unless otherwise authorized by the National Competent Authority. For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

e.g. pharmaceutical (small molecule)

生物化学的／生理学的作用

Brivaracetam shows approximately 10 times greater potency than levetiracetam (Keppra)*; pIC50 at LBS = 7.0; inhibits audiogenic seizures in seizure-prone mice (ED50 = 14 μmol/kg) and is also effective in other animal models of epilepsy. Brivaracetam is used as an anticonvulsant (antiepileptic) for seizure treatment.

包装

Unit quantity: 160mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit EDQM reference substance catalogue.

その他情報

Sales restrictions may apply.

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable